CoreSys Two is a non-invasive medical monitoring system designed to analyze early physiological changes associated with the inflammatory response and the patient’s autonomic state.

Based on the same analysis technology as CoreSys One, it combines brain activity (EEG) and cardiac activity (ECG + HRV) to provide an integrated view of the patient’s physiological status in real time.

The system integrates medical-grade sensors, a compact and robust Easy Connect module, and a Samsung tablet selected for clinical environments where a medical-grade tablet is not required. This configuration provides an advanced, practical, and adaptable monitoring solution to meet the needs of different hospital markets.

EEG and ECG signals are processed through ANFIS artificial intelligence technology, generating the TSI (Trend of Sepsis and Inflammation Index), an advanced indicator based on the evolution of physiological parameters.

TSI does not identify bacteria or locate infections; it provides information on physiological changes associated with inflammatory processes, helping healthcare professionals gain a more comprehensive view of the patient’s condition.

Key Technical Features

• Non-invasive monitoring of brain and cardiac activity.
• TSI Index based on EEG, ECG, and HRV processed through ANFIS AI technology.
• Samsung tablet with dedicated clinical software.
• USB-C connectivity and HL7 integration readiness.
• Continuous monitoring for up to 30 days.
• Compact, lightweight, and robust Easy Connect module.
• Configuration designed for markets and clinical environments that do not require a medical-grade tablet.

System Configuration

CoreSys Two offers the same physiological analysis technology and TSI Index as CoreSys One, in a configuration optimized for flexible implementation.

The expansion with the Cardiac Output (CCO) module is available exclusively for CoreSys One.

Regulatory Information

The availability of this product may vary by country and applicable regulatory requirements. Please contact us to confirm the regulatory status and availability in your market.